TY - CHAP M1 - Book, Section TI - The Goodman & Gilman Year in Review: 2017 New and Noteworthy FDA Approvals A1 - Murri, PharmD, MBA, Nelda A2 - Brunton, Laurence L. A2 - Hilal-Dandan, Randa A2 - Knollmann, Björn C. PY - 2017 T2 - Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13e AB - In 2017 the U.S. Food and Drug Administration (FDA) approved 40 new drugs and granted 48 noteworthy biologic licenses. The 40 new drugs are cataloged in Part 1. Among them are: SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - accessmedicine.mhmedical.com/content.aspx?aid=1179320463 ER -